Search results
Optimizing production to save time, improve yield, and increase safety. Learn More. Discover Asymchem, a top CDMO serving global pharma companies with innovative green solutions, advanced drug development, and manufacturing services.
Asymchem has invested in a complete bio-enzyme catalysis technology platform supporting a library of more than 2300 enzymes, many used in the production of statins, glitazones, penem antibiotics and other
Asymchem Group | 11,856 followers on LinkedIn. A leading global CMC/CDMO providing fully integrated solutions in chemical-pharmaceutical and biologic sectors. | At Asymchem we are proud of the...
May 21, 2024 · Asymchem Laboratories is expanding its global footprint by taking on Pfizer’s leftovers in Sandwich, England. | Pfizer downsized much of its operations at the site, where it first discovered ...
A leading global CMC/CDMO providing fully integrated solutions in chemical-pharmaceutical and biologic sectors. | At Asymchem we are proud of the strides that we have made since our founding in...
At Asymchem, we know how to help biotech and emerging pharmaceutical companies get things done. We’ve gained our knowledge over 20 years as a CDMO, helping big pharma launch therapeutics.
May 21, 2024 · Asymchem is a global technology-driven contract development and manufacturing organization (CDMO) providing services to the pharmaceutical industry. Founded in 1997, Asymchem employs over 9300...
May 21, 2024 · Asymchem will continue to operate the site in Sandwich, Kent, as a clinical small molecule development and manufacturing facility to meet global client demands for pharma services and supply. The...
May 21, 2024 · TEDA TIANJIN, China--(BUSINESS WIRE)--Asymchem Laboratories (Tianjin) Co., Ltd. (Stock Code 002821.SZ/6821.HK) announced today that it will operate the former Pfizer U.K. small molecule API...
Asymchem is a large USFDA-inspected Contract Development and Manufacturing Organization (CDMO), renowned for its expertise in developing sustainable processes for late-phase to commercial small molecule and peptide Active Pharmaceutical Ingredients (APIs).
